In Focus

Read more about our Clinical Trials staff’s insights, conference participation, awards, and publications. Our team of dedicated experts are prominent within the industry and bring innovation to all our clinical studies.

Supporting CDISC Adoption Across the NCI Community

09/2022
Westat expertise in is on hand at the 24th SCDM Annual Conference, held September 11-14, 2022, in San Antonio, Texas.
  • Conference

Clinical Trials Site Monitoring Expertise at 2022 SOCRA

09/2022
Westat site monitoring expertise will be spotlighted in 2 posters at the 31st Annual SOCRA Conference, which will be held virtually September 14-17, 2022.
  • Conference
View Lauren Laimon profile.

Lauren Laimon on 2022 Top 50 Women Leaders of Maryland

07/2022
Lauren Laimon, M.S., a Westat Senior Study Director for Clinical Trials, has been selected as one of the 2022 Top 50 Women Leaders of Maryland by Women We Admire.
  • Publication
Read more on First Patient Enrolled in HIV Combination Maintenance Therapy Study

First Patient Enrolled in HIV Combination Maintenance Therapy Study

07/2022
Built on a long-standing partnership with TaiMed Biologics, Inc., (TaiMed), Westat and TaiMed have announced the first patient has been enrolled in the new TMB-a21 study. TMB-a21 is a Phase 1b/2a study involving HIV-1 infected patients who are virally suppressed.
  • Publication

Westat Presents at 2022 DIA Annual Meeting

06/2022
Westat’s Clinical Trials staff Julia Solarczyk Donnelly and Melissa King will present their poster, A Contract Research Organization’s (CRO) Experience Serving as a Regulatory Sponsor – A Case Study, on Monday, June 20, 2022, at the 2022 Drug Information Association’s (DIA) Annual Meeting.
  • Conference

Westat Sponsors Texas Life Science Forum

02/2022
Westat is a proud sponsor of the Texas Life Science Forum, taking place in Houston, Texas, on Thursday, February 24, 2022. The forum is the premier life science event in Texas that brings together members from industry, emerging life science companies, academic, and investors.
  • Conference

What Pneumonia Vaccine Prompts the Best Immunity Response in Infants Whose Mothers Have HIV?

01/2022
New research compares immune responses of 2 pneumonia vaccines, PCV-10 and PPV-23, and found that PPV-23 provided during pregnancy to be more beneficial to the infants.
  • Publication

First Next-Generation Freeze-Dried Plasma (FDP) Product Found to Be as Safe and Potent as Fresh Frozen Plasma (FFP) | Westat

01/2022
Data from a phase 1 dose-escalation trial reveals that a first next-generation freeze-dried plasma (FDP) product retains the same potency and safety of fresh frozen plasma (FFP).
  • Publication
In Focus Pages